EXHIBITOR FLIP BOOK
Juven is targeted nutrition therapy with arginine, glutamine, Beta-Hydroxy-Beta-Methylbutyrate (HMB), and collagen protein to support tissue building. Clinically shown to support wound healing by enhancing collagen formation in as little as 2 weeks.* *Studied in healthy elderly adults as part of a wound healing model, taking 2 servings per day. Williams JZ et all. Ann Surg 2002:236:369-375. For use under medical supervision. Š2020 Abbott XXXXXX/March 2020
The toughest challenges. The most advanced science.
We fight the toughest health challenges with advanced science, putting our passion to work where the need is greatest. Because our purpose as a global biopharmaceutical company is to make a remarkable impact on people’s lives. It takes all of us to turn possibilities into medicine that reaches millions. So we partner with governments, academic institutions, scientific and advocacy groups to make it happen. Together, we’re inventing the future of medicine.
Learn more at abbvie.com
TRANSFORMING THE LANGUAGE OF LIFE INTO VITAL MEDICINES At Amgen, we believe that the answers to medicine’s most pressing questions are written in the language of our DNA. As pioneers in biotechnology, we use our deep understanding of that language to create vital medicines that address the unmet needs of patients fighting serious illness – to dramatically improve their lives. For more information about Amgen, our pioneering science and our vital medicines, visit www.amgen.com
Amgen is a proud sponsor of the 1FOOTZMWBOJB "DBEFNZ PG %FSNBUPMPHZ BOE %FSNBUPMPHJD 4VSHFSZ
©20 Amgen Inc. All rights reserved.
The Most Objective Second Opinion When a Diagnosis is Uncertain
~1 7 IN
of all melanocytic lesions may be equivocal1-3
Diagnostic Accuracy Leads to Better Patient Care myPath Melanoma® is a clinically validated diagnostic test that can differentiate benign nevi from melanoma.
23 genes
Accuracy: 94% sensitivity, 96% specificity4
Over 38,000 lesions tested
Results within 6 days
20 publications discuss the accuracy of myPath
Decreases unnecessary re-excisions by 80%5
Covered by Medicare and commercial insurance
9 out of 10 patients pay $0*
*After insurance and financial assistance.
The Myriad Promise™ is our commitment to provide patients with access to accurate and affordable genetic results. For billing questions: 844-697-4239 or billinghelp@myriad.com
For more information visit myPathMelanoma.com or call 800.231.4442 Myriad Dermatology // 320 Wakara Way, Salt Lake City, UT 84108 ©2020 Myriad Genetics, Inc. All rights reserved. Myriad, Myriad myPath, Myriad Promise and their respective logos are either trademarks or registered trademarks of Myriad Genetics, Inc. in the United States and other jurisdictions. MGMPOVERVIEW / 10-20 1. Shoo BA et al. Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center. J Am Acad Dermatol. 2010;62(5):751-756. 2. Veenhuizen KC et al. Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party. The Journal of pathology. 1997;182(3):266-272. 3. Elmore JG et al. Pathologists’ diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study. BMJ (Clinical research ed). 2017;357:j2813. 4. Ko J et al. CEBP 2017;26(7):1107-1113. 5. Cockerell et al. The influence of a gene-expression signature on the treatment of diagnostically challenging melanocytic lesions. Per Med. 2017;14(2):123-130.
AN INDICATION THAT HAS EXPANDED Find out more at DupixentHCP.com
© 2020 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
DUP.20.07.0800
We’re UCB. Nice to meet you. At UCB, we celebrate people like you who share our commitment to advancing the discussion, understanding, and treatment of dermatological conditions.
We want to get to know you. We recognize now, more than ever, the power of connectivity. We look forward to getting to know you both virtually and in person soon.
We want you to get to know us. Learn more about us at UCBforDerm.com/X, or send us an email at GetToKnowUs@UCB.com. Let’s talk about our shared commitment to driving dermatology forward.
©2020 UCB, Inc., Smyrna, GA 30080. All rights reserved. August, 2020. US-P-DA-PSO-2000088
Homework: math History, science
s e r o h c , e s g u o n H ccumi a v , t g e n s i dust nize clo ro ga